Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study

Fig. 3

The relationship between warfarin or ACEI/ARB and vascular calcification volume. In univariate analyses, use of warfarin was significantly associated with vascular calcification volume (p = 0.0287). ACEI/ARB was marginally associated with vascular calcification volume (p = 0.0586). a, warfarin. b, ACEI/ARB. ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin II receptor blocker; BSA, body surface area calculated with Fujimoto’s formula; Calc, calcification volume

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us